Swiss Life Asset Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Swiss Life Asset Management's ABMD Position: Q4 2022 in Review
Swiss Life Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,344 shares — an estimated $575K sold.
Swiss Life Asset Management first reported a position in ABMD in Q2 2018 and held it in 9 quarters. The position peaked at $8.65M in Q2 2019. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Swiss Life Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Swiss Life Asset Management sold 2,344 Abiomed Inc shares in Q4 2022, an estimated $575K.
- Swiss Life Asset Management first reported a position in Abiomed Inc in Q2 2018 and held it in 9 quarters.
- Swiss Life Asset Management's Abiomed Inc position peaked at $8.65M in Q2 2019.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Swiss Life Asset Management's 13F filing for Q4 2022, filed 9 Dec 2025.